Literature DB >> 12467665

Purification and characterization of an anticoagulant phospholipase A(2) from Indian monocled cobra (Naja kaouthia) venom.

Robin Doley1, Ashis Kumar Mukherjee.   

Abstract

An anticoagulant, non-toxic phospholipase A(2) was isolated from the venom of Indian monocled cobra (Naja kaouthia) by a combination of ion-exchange chromatography on CM-Sephadex C-50 and gel filtration on Sephadex G-50. This purified protein named NK-PLA(2)-I, had a subunit molecular mass of 13.6 kDa and migrated as a dimer under non-reduced condition in SDS-PAGE. NK-PLA(2)-I was a highly thermostable protein requiring basic pH optima for its catalytic activity and showed preferential hydrolysis of phosphotidylcholine. This protein exhibited higher anticoagulant, indirect hemolysis, liver and heart tissue damaging activity but exerted less toxicity, direct hemolysis, edema and lung tissue damaging activity as compared to whole venom. Treatment of NK-PLA(2)-I with rho-BPB, TPCK, PMSF, antivenom and heating had almost equal effect on PLA(2), and other pharmacological properties except in vitro tissue damaging activity. Current investigation provides a fairly good indication that NK-PLA(2)-I induces various pharmacological effects by mechanisms, which are either dependent or independent of its catalytic activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12467665     DOI: 10.1016/s0041-0101(02)00213-1

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  12 in total

1.  Fibrinogenolytic toxin from Indian monocled cobra (Naja kaouthia) venom.

Authors:  C Chandra Sekhar; Dibakar Chakrabarty
Journal:  J Biosci       Date:  2011-06       Impact factor: 1.826

2.  Effect of piratoxin II and acutohaemolysin phospholipase (PLA2) proteins on myristic fatty acid--an ONIOM and DFT study.

Authors:  Angamuthu Abiram; Ponmalai Kolandaivel
Journal:  J Mol Model       Date:  2010-03-12       Impact factor: 1.810

3.  Nattokinase-heparin exhibits beneficial efficacy and safety-an optimal strategy for CKD patients on hemodialysis.

Authors:  Hao Wu; Huan Wang; Wei Li; Chi Zhang; Yushan Liu; Feng Xu; Jiepeng Chen; Lili Duan; Fengjiao Zhang
Journal:  Glycoconj J       Date:  2019-02-20       Impact factor: 2.916

4.  Green synthesis of silver nanoparticles using Indian male fern (Dryopteris Cochleata), operational parameters, characterization and bioactivity on Naja naja venom neutralization.

Authors:  Pushpendra Singh; Mohammad Yasir; Ruchi Khare; Rahul Shrivastava
Journal:  Toxicol Res (Camb)       Date:  2020-10-15       Impact factor: 3.524

5.  Non-covalent interaction of phospholipase A(2) (PLA(2)) and kaouthiotoxin (KTX) from venom of Naja kaouthia exhibits marked synergism to potentiate their cytotoxicity on target cells.

Authors:  Ashis K Mukherjee
Journal:  J Venom Res       Date:  2010-09-30

6.  Two acidic, anticoagulant PLA2 isoenzymes purified from the venom of monocled cobra Naja kaouthia exhibit different potency to inhibit thrombin and factor Xa via phospholipids independent, non-enzymatic mechanism.

Authors:  Ashis K Mukherjee; Bhargab Kalita; Rupamoni Thakur
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

7.  Anticoagulant mechanism, pharmacological activity, and assessment of preclinical safety of a novel fibrin(ogen)olytic serine protease from leaves of Leucas indica.

Authors:  Debananda Gogoi; Neha Arora; Bhargab Kalita; Rahul Sarma; Taufikul Islam; Sidhhartha S Ghosh; Rajlakshmi Devi; Ashis K Mukherjee
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

8.  Humanized-single domain antibodies (VH/VHH) that bound specifically to Naja kaouthia phospholipase A2 and neutralized the enzymatic activity.

Authors:  Charnwit Chavanayarn; Jeeraphong Thanongsaksrikul; Kanyarat Thueng-In; Kunan Bangphoomi; Nitat Sookrung; Wanpen Chaicumpa
Journal:  Toxins (Basel)       Date:  2012-07-19       Impact factor: 4.546

9.  Quantifying Demyelination in NK venom treated nerve using its electric circuit model.

Authors:  H K Das; D Das; R Doley; P P Sahu
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

10.  Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation.

Authors:  Matthew Lewin; Stephen Samuel; Janie Merkel; Philip Bickler
Journal:  Toxins (Basel)       Date:  2016-08-25       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.